Design, synthesis and biological evaluation of novel pyrrolo[1,2-b]pyridazin-2(1H)-ones as selective PARP1 inhibitors for cancer therapy
Fields of Study & Subjects
PARP inhibition in cancer therapy
Advanced Breast Cancer Therapies
Synthesis and Reactivity of Heterocycles
Publication details
- Journal / source
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Volume
- 307
- Pages
- 118650–118650
- Publication date
- 4 February 2026
- Language
- EN